Skip to main content
Top
Published in: Thyroid Research 1/2010

Open Access 01-12-2010 | Research

Prognostic value of lymph node metastases of differentiated thyroid cancer (DTC) according to the local advancement and range of surgical excision

Authors: Agnieszka Czarniecka, Michal Jarzab, Jolanta Krajewska, Ewa Chmielik, Bogna Szcześniak-Klusek, Ewa Stobiecka, Robert Kokot, Aleksander Sacher, Stanisław Poltorak, Jan Wloch

Published in: Thyroid Research | Issue 1/2010

Login to get access

Abstract

In differentiated thyroid carcinoma (DTC) with primary tumor smaller than 1 cm, the routine central lymph node (LN) dissection is questioned, due to increased risk of post-surgery complications and lack of confirmed benefit.

Aim

The analysis of prognostic significance of LN metastases, in DTC patients to verify the potential role of central neck lymphadenectomy on disease staging.

Materials and methods

The group of 195 DTC patients, primarily operated between 2004 and 2005, was retrospectively analyzed. 184 patients after radical operation, with no distant metastases diagnosed before surgery, were included into analysis. LN metastases were observed in 55 of cases (28%). In 124 cases only dissection of central LN compartment was performed, in 36 patients also uni- or bilateral modified cervical lymphadectomy was carried out. In 24 patients with tumor limited to the thyroid gland without suspicious lymph nodes, the routine central lymph node dissection was not done.

Results

Median follow-up was 4 years. The 5-year overall and disease free survival standardized ratio were 100% and 95% respectively. The risk of LN metastases increased with the more locally advanced cancer. In the group of 124 patients, in whom only central LN dissection was performed, LN metastases were diagnosed in 15 cases (12%). No significant relation between multifocality and frequency of central and/or lateral LN metastases was noticed. Significant correlation between N feature and extrathyroidal invasion was observed (p = 0,0003). The presence of LN metastases was related to worsening of disease free survival from 99 to 90%. During the follow-up recurrence occurred in 6 (3%) cases. In 24 patients in whom only total thyroidectomy was done, no local or distant recurrence was observed. The assessment of early postoperative complications (hypoparathyroidism, paresis of vocal cords) indicated that the frequency of early calcium balance disturbances was significantly lower in patients in whom central LN dissection was not performed (p = 0,04)

Conclusions

Our result indicate that in the early diagnosis of thyroid cancer, the occurrence of LN DTC metastases is rarer and was observed only in 12% of elective dissections of central LN node compartment, if no lateral dissection was indicated due to the lack of clinical suspicion. In DTC patients with tumor diameter <1 cm and no sonographical or inraoperative suspicion on LN involvement, routine central lymphadenectomy may be not obligatory.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zaydfudim V, Feurer ID, Griffin MR, Phay JE: The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 2008,44(6):1070–7. discussion 1077–8 10.1016/j.surg.2008.08.034CrossRef Zaydfudim V, Feurer ID, Griffin MR, Phay JE: The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 2008,44(6):1070–7. discussion 1077–8 10.1016/j.surg.2008.08.034CrossRef
2.
go back to reference Witte J, Goretzki PE, Dieken J, Simon D, Roher HD: Importance of lymph node metastases in follicular thyroid cancer. World J Surg 2002,26(8):1017–1022. 10.1007/s00268-002-6668-yPubMedCrossRef Witte J, Goretzki PE, Dieken J, Simon D, Roher HD: Importance of lymph node metastases in follicular thyroid cancer. World J Surg 2002,26(8):1017–1022. 10.1007/s00268-002-6668-yPubMedCrossRef
3.
go back to reference Machens A, Hinze R, Thomusch O, Dralle H: Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002,26(1):22–28. 10.1007/s00268-001-0176-3PubMedCrossRef Machens A, Hinze R, Thomusch O, Dralle H: Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002,26(1):22–28. 10.1007/s00268-001-0176-3PubMedCrossRef
4.
go back to reference Pacini F, Elisei R, Capezzone M, Miccoli P, Molinaro E, Basolo F, Agate L, Bottici V, Raffaelli M, Pinchera A: Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid 2001,11(9):877–881. 10.1089/105072501316973145PubMedCrossRef Pacini F, Elisei R, Capezzone M, Miccoli P, Molinaro E, Basolo F, Agate L, Bottici V, Raffaelli M, Pinchera A: Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid 2001,11(9):877–881. 10.1089/105072501316973145PubMedCrossRef
5.
go back to reference Czarniecka A: Indication for less than total thyroidectomy in differentiated thyroid cancer. Zabrze, Poland Silesian Medical University; 2004. Czarniecka A: Indication for less than total thyroidectomy in differentiated thyroid cancer. Zabrze, Poland Silesian Medical University; 2004.
6.
go back to reference Cady B: Presidential address: beyond risk groups--a new look at differentiated thyroid cancer. Surgery 1998,124(6):947–957.PubMedCrossRef Cady B: Presidential address: beyond risk groups--a new look at differentiated thyroid cancer. Surgery 1998,124(6):947–957.PubMedCrossRef
7.
go back to reference Ortiz S, Rodriguez JM, Parrilla P, Perez D, Moreno-Gallego A, Rios A, Soria T: Recurrent papillary thyroid cancer:analysis of prognostic factors including the histological variant. Eur J Surg 2001,167(6):406–412. 10.1080/110241501750243734PubMedCrossRef Ortiz S, Rodriguez JM, Parrilla P, Perez D, Moreno-Gallego A, Rios A, Soria T: Recurrent papillary thyroid cancer:analysis of prognostic factors including the histological variant. Eur J Surg 2001,167(6):406–412. 10.1080/110241501750243734PubMedCrossRef
8.
go back to reference Tzavara I, Vlassopoulou B, Alevizaki C, Koukoulis G, Tzanela M, Koumoussi P, Sotsiou F, Thalassinos N: Differentiated thyroid cancer: a retrospective analysis of 832 cases from Greece. Clin Endocrinol (Oxf) 1999,50(5):643–654. 10.1046/j.1365-2265.1999.00715.xCrossRef Tzavara I, Vlassopoulou B, Alevizaki C, Koukoulis G, Tzanela M, Koumoussi P, Sotsiou F, Thalassinos N: Differentiated thyroid cancer: a retrospective analysis of 832 cases from Greece. Clin Endocrinol (Oxf) 1999,50(5):643–654. 10.1046/j.1365-2265.1999.00715.xCrossRef
9.
go back to reference Kobayashi T, Asakawa H, Komoike Y, Tamaki Y, Monden M: Characteristics and prognostic factors in patients with differentiated thyroid cancer who underwent a total or subtotal thyroidectomy: surgical approach for high-risk patients. Surg Today 1999,29(3):200–203. 10.1007/BF02483006PubMedCrossRef Kobayashi T, Asakawa H, Komoike Y, Tamaki Y, Monden M: Characteristics and prognostic factors in patients with differentiated thyroid cancer who underwent a total or subtotal thyroidectomy: surgical approach for high-risk patients. Surg Today 1999,29(3):200–203. 10.1007/BF02483006PubMedCrossRef
10.
go back to reference Mazzaferri EL, Kloos RT: Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001,86(4):1447–1463. 10.1210/jc.86.4.1447PubMedCrossRef Mazzaferri EL, Kloos RT: Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001,86(4):1447–1463. 10.1210/jc.86.4.1447PubMedCrossRef
11.
go back to reference Beenken S, Roye D, Weiss H, Sellers M, Urist M, Diethelm A, Goepfert H: Extent of surgery for intermediate-risk well-differentiated thyroid cancer. Am J Surg 2000,179(1):51–56. 10.1016/S0002-9610(99)00254-8PubMedCrossRef Beenken S, Roye D, Weiss H, Sellers M, Urist M, Diethelm A, Goepfert H: Extent of surgery for intermediate-risk well-differentiated thyroid cancer. Am J Surg 2000,179(1):51–56. 10.1016/S0002-9610(99)00254-8PubMedCrossRef
12.
go back to reference Gimm O, Dralle H: Lymphadenectomy for thyroid and lymph node carcinomas. Chirurg 2007,78(3):182. 184–8,190–3 10.1007/s00104-007-1303-yPubMedCrossRef Gimm O, Dralle H: Lymphadenectomy for thyroid and lymph node carcinomas. Chirurg 2007,78(3):182. 184–8,190–3 10.1007/s00104-007-1303-yPubMedCrossRef
13.
go back to reference Mathonnet M: Lymph node dissection in non-medullary differentiated thyroid carcinoma. Ann Chir 2006,131(6–7):361–8. 10.1016/j.anchir.2005.10.009PubMedCrossRef Mathonnet M: Lymph node dissection in non-medullary differentiated thyroid carcinoma. Ann Chir 2006,131(6–7):361–8. 10.1016/j.anchir.2005.10.009PubMedCrossRef
14.
go back to reference Mann B, Buhr HJ: Lymph node dissection in patients with differentiated thyroid carcinoma--who benefits? Langenbecks Arch Surg 1998,383(5):355–8. 10.1007/s004230050148PubMedCrossRef Mann B, Buhr HJ: Lymph node dissection in patients with differentiated thyroid carcinoma--who benefits? Langenbecks Arch Surg 1998,383(5):355–8. 10.1007/s004230050148PubMedCrossRef
15.
go back to reference Vorländer C, Lienenlüke RH, Wahl RA: Lymph node dissection in papillary and follicular thyroid cancer. Chirurg 2008,79(6):564–70. 10.1007/s00104-008-1489-7PubMedCrossRef Vorländer C, Lienenlüke RH, Wahl RA: Lymph node dissection in papillary and follicular thyroid cancer. Chirurg 2008,79(6):564–70. 10.1007/s00104-008-1489-7PubMedCrossRef
16.
go back to reference Bononi M, Tocchi A, Cangemi V, Vecchione A, Giovagnoli MR, De Cesare A, Fiori E, Volpino P, Brozzetti S, Meucci M, Scozzafava S, Cavallaro : Lymph node dissection in papillary or follicular thyroid carcinoma. Anticancer Res 2004,24(4):2439–42.PubMed Bononi M, Tocchi A, Cangemi V, Vecchione A, Giovagnoli MR, De Cesare A, Fiori E, Volpino P, Brozzetti S, Meucci M, Scozzafava S, Cavallaro : Lymph node dissection in papillary or follicular thyroid carcinoma. Anticancer Res 2004,24(4):2439–42.PubMed
17.
go back to reference Palestini N, Borasi A, Cestino L, Freddi M, Odasso C, Robecchi A: Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbecks Arch Surg 2008,393(5):693–8. 10.1007/s00423-008-0360-0PubMedCrossRef Palestini N, Borasi A, Cestino L, Freddi M, Odasso C, Robecchi A: Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbecks Arch Surg 2008,393(5):693–8. 10.1007/s00423-008-0360-0PubMedCrossRef
18.
go back to reference Handkiewicz-Junak D, Czarniecka A, Jarzab B: Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions. Mol Cell Endocrinol 2010,322(1–2):8–28. 10.1016/j.mce.2010.01.007PubMedCrossRef Handkiewicz-Junak D, Czarniecka A, Jarzab B: Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions. Mol Cell Endocrinol 2010,322(1–2):8–28. 10.1016/j.mce.2010.01.007PubMedCrossRef
Metadata
Title
Prognostic value of lymph node metastases of differentiated thyroid cancer (DTC) according to the local advancement and range of surgical excision
Authors
Agnieszka Czarniecka
Michal Jarzab
Jolanta Krajewska
Ewa Chmielik
Bogna Szcześniak-Klusek
Ewa Stobiecka
Robert Kokot
Aleksander Sacher
Stanisław Poltorak
Jan Wloch
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Thyroid Research / Issue 1/2010
Electronic ISSN: 1756-6614
DOI
https://doi.org/10.1186/1756-6614-3-8

Other articles of this Issue 1/2010

Thyroid Research 1/2010 Go to the issue